Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Enrollment ongoing in phase II study of LX-9211 in postherpetic neuralgia

Dec. 24, 2020

Phase III study of SPN-812 for adult ADHD meets primary endpoint

Dec. 23, 2020

Disease-modifying anle-138b enters phase Ib study in patients with Parkinson's disease

Dec. 23, 2020

FDA places clinical hold on RESTORE-1 trial of NBIb-1817

Dec. 23, 2020

Mouse model of malformations of cortical development and epilepsy

Dec. 23, 2020

Stem cell-derived vesicles protective against neonatal hemorrhage

Dec. 22, 2020

Sage Therapeutics has patented GABA(A) receptor modulators

Dec. 22, 2020

Fintepla approved in Europe for the treatment of seizures in Dravet syndrome

Dec. 22, 2020

Nanoform announces first human dosing with nanoformed drug

Dec. 21, 2020

XEN-496 shows comparable PK data to that of retigabine

Dec. 21, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...